as of —
₹—
Change
—
Day Open
₹—
Day High
₹—
Day Low
₹—
NSE Close — 19 Nov 2026
₹64.71
Change
+1.14 (1.79%)
Open
₹63.52
Prev. Close
₹63.57
Day High
₹64.88
Day Low
₹63.52
Volume Analysis
Traded
935,903
Delivered
674,079
Delivery %
72.02%
End-of-day NSE price via the official Bhavcopy — updated once daily after market close, not a live tick.
Pivot Levels
| Type | R3 | R2 | R1 | Pivot | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | ₹66.58 | ₹65.73 | ₹65.22 | ₹64.37 | ₹63.86 | ₹63.01 | ₹62.5 |
| Fibonacci | ₹65.73 | ₹65.21 | ₹64.89 | ₹64.37 | ₹63.85 | ₹63.53 | ₹63.01 |
| Camarilla | ₹65.08 | ₹64.96 | ₹64.83 | ₹64.37 | ₹64.59 | ₹64.46 | ₹64.34 |
Support/resistance levels for today, calculated from the previous trading day's high/low/close.
Absolute Returns
YTD
+6.08%
1 Week
+2.63%
1 Month
+14.69%
3 Months
+9.25%
6 Months
+16.66%
1 Year
+6.69%
2Y/3Y/5Y not shown yet — price history tracking only goes back to mid-2025 so far.
Company Overview
Source: Screener.in (Consolidated figures) — data as of 17 Nov 2026. Not investment advice.
TopFund Analysis
Icicipramc - Ipru5008 holds up reasonably well on TopFund's composite fundamentals check, at 66/100. The strongest factor is Risk & Volatility (68/100), while Liquidity (64/100) is the weakest area to weigh before deciding.
TopFund Score — Fundamentals Quality
66/100 — GoodData confidence: 56/100 (Moderate Confidence) — based on how complete and how fresh the underlying data is.
As of 19 Nov 2026 · How we calculate this →
Risk & Volatility
Liquidity
Not investment advice — an automated read of public fundamentals data, for research context only.
Which Mutual Funds Hold Icicipramc - Ipru5008?
Frequently Asked Questions about Icicipramc - Ipru5008
Icicipramc - Ipru5008 (BANKIETF) closed at ₹64.71 on NSE on 19 November 2026, up 1.14 (1.79%) from the previous close.
Icicipramc - Ipru5008 trades on the NSE (National Stock Exchange of India) under the symbol BANKIETF.
Icicipramc - Ipru5008 has a TopFund Quality Score of 66/100 (Good), a composite of profitability, balance-sheet health, growth and valuation. This is an analytical score based on public data, not personalized investment advice — see the full breakdown below before deciding.
Community Sentiment
What are other investors saying about Icicipramc - Ipru5008?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
Sign in to join the discussionNo comments yet — start the discussion.